Literature DB >> 3111845

The conserved decanucleotide from the immunoglobulin heavy chain promoter induces a very high transcriptional activity in B-cells when introduced into an heterologous promoter.

M Dreyfus, N Doyen, F Rougeon.   

Abstract

A conserved decanucleotide (ATGCAAATNA) is present 45-60 nucleotides upstream from the transcription startpoint in all immunoglobulin heavy chain promoters (VH promoters). We have introduced this decanucleotide (cd sequence) at a similar position into the upstream flanking sequence of the mouse Renin-1 gene. This gene is only transcribed in highly specialized tissues, and the fragment used here (-449 to +30 with respect to the main transcription startpoint) has little promoter activity in fibroblastic or myeloma cell lines, even if coupled to a functional enhancer. In contrast, after insertion of the decanucleotide, this fragment, while still inactive in non-lymphoid cells, becomes a potent promoter in B-cells when associated with SV40 or immunoglobulin heavy chain enhancer. In all respects, the engineered fragment behaves like an authentic VH promoter isolated in this laboratory, except that it is even more active in B-cells. Deletion experiments show that all renin sequences are dispensable for the activity of the chimaeric promoter, except probably for the renin TATA box which defines the precise transcription startpoint. We conclude that the decanucleotide is sufficient to activate a promoter in B-cells but not in non-B-cells, and therefore that no other element is needed to account for the B-cell specificity of the VH promoter. In addition, our results suggest that the lack of activity of the renin promoter in non cognate cells is not due to the binding of a repressor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111845      PMCID: PMC553542          DOI: 10.1002/j.1460-2075.1987.tb02418.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Nuclear factors bind to regulatory regions of the mouse kappa immunoglobulin gene.

Authors:  R Hromas; B Van Ness
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

Review 2.  Cell-type specific regulation of a kappa immunoglobulin gene by promoter and enhancer elements.

Authors:  C Queen; J Foster; C Stauber; J Stafford
Journal:  Immunol Rev       Date:  1986-02       Impact factor: 12.988

3.  Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences.

Authors:  N F Landolfi; J D Capra; P W Tucker
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

4.  Distinct factors bind to apparently homologous sequences in the immunoglobulin heavy-chain enhancer.

Authors:  J Weinberger; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Aug 28-Sep 3       Impact factor: 49.962

5.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes.

Authors:  H Singh; R Sen; D Baltimore; P A Sharp
Journal:  Nature       Date:  1986 Jan 9-15       Impact factor: 49.962

Review 6.  Gene regulation by proteins acting nearby and at a distance.

Authors:  M Ptashne
Journal:  Nature       Date:  1986 Aug 21-27       Impact factor: 49.962

7.  Regulation of rat insulin 1 gene expression: evidence for negative regulation in nonpancreatic cells.

Authors:  U Nir; M D Walker; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

8.  Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts.

Authors:  I Davidson; C Fromental; P Augereau; A Wildeman; M Zenke; P Chambon
Journal:  Nature       Date:  1986 Oct 9-15       Impact factor: 49.962

9.  The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells.

Authors:  C Wasylyk; B Wasylyk
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

10.  The mouse immunoglobulin heavy-chain enhancer: effect on transcription in vitro and binding of proteins present in HeLa and lymphoid B cell extracts.

Authors:  P Augereau; P Chambon
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

View more
  53 in total

1.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

2.  Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins.

Authors:  E Schreiber; K Harshman; I Kemler; U Malipiero; W Schaffner; A Fontana
Journal:  Nucleic Acids Res       Date:  1990-09-25       Impact factor: 16.971

3.  Xenopus laevis Oct-1 does not bind to certain histone H2B gene promoter octamer motifs for which a novel octamer-binding factor has high affinity.

Authors:  D P Smith; R W Old
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

4.  Promoters with the octamer DNA motif (ATGCAAAT) can be ubiquitous or cell type-specific depending on binding affinity of the octamer site and Oct-factor concentration.

Authors:  I Kemler; E Bucher; K Seipel; M M Müller-Immerglück; W Schaffner
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

5.  Octamer-binding proteins in diverse hemopoietic cells.

Authors:  P N Cockerill; S P Klinken
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  Identification of a novel factor that interacts with an immunoglobulin heavy-chain promoter and stimulates transcription in conjunction with the lymphoid cell-specific factor OTF2.

Authors:  B K Yoza; R G Roeder
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

7.  Lymphoid-specific transcriptional activation by components of the IgH enhancer: studies on the E2/E3 and octanucleotide elements.

Authors:  G P Cook; M S Neuberger
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

8.  Identification of an octamer-binding site in the human kappa light-chain enhancer.

Authors:  K Nelms; B Van Ness
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  Every enhancer works with every promoter for all the combinations tested: could new regulatory pathways evolve by enhancer shuffling?

Authors:  M Kermekchiev; M Pettersson; P Matthias; W Schaffner
Journal:  Gene Expr       Date:  1991-04

10.  A distinct octamer-binding protein present in malignant melanoma cells.

Authors:  P M Cox; S M Temperley; H Kumar; C R Goding
Journal:  Nucleic Acids Res       Date:  1988-12-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.